Editas Medicine, Inc.EDITNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank92
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.14
↑ 87% vs avg
Percentile
P92
Near historical high
Streak
1 yr
Consecutive declineElevated
Average
-9.06
Historical baseline
PeriodValueYoY Change
2025-1.14-157.7%
2024-0.44+91.2%
2023-5.02-81.8%
2022-2.76+70.4%
2021-9.33+73.7%
2020-35.43-220.2%
2019-11.07-13.6%
2018-9.74+5.4%
2017-10.30-91.4%
2016-5.38-